Q02293 (FNTB_RAT) Rattus norvegicus (Rat)
Protein farnesyltransferase subunit beta UniProtKBInterProSTRINGInteractive Modelling
437 aa; Sequence (Fasta) ;
1 identical sequence: Ranitomeya imitator: A0A822D9Z9
It is possible new templates exist for this target since these models were created.
Available Structures
45 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Ligands | ||
|---|---|---|---|---|---|---|
| CRYSTAL STRUCTURE OF PROTEIN FARNESYLTRANSFERASE AT 2.25 ANGSTROMS RESOLUTION |
Heteromer Q04631; | 1×ZN; | ||||
| Assess | ||||||
| Protein farnesyltransferase complexed with FPP and ethylenediamine scaffold inhibitor 7 |
Heteromer Q04631; | 1×ZN; 1×FPP; 1×ED7; | ||||
| Assess | ||||||
| CO-CRYSTAL STRUCTURE OF RAT PROTEIN FARNESYLTRANSFERASE COMPLEXED WITH A K-RAS4B PEPTIDE SUBSTRATE … |
Heteromer P01116; Q04631; | 1×ZN; 4×ACT; 1×FII; | ||||
| Assess | ||||||
| CRYSTAL STRUCTURE OF RAT PROTEIN FARNESYLTRANSFERASE COMPLEXED WITH THE NON-SUBSTRATE TETRAPEPTIDE … |
Heteromer Q04631; | 2×ACY; 1×ZN; 1×FPP; | ||||
| Assess | ||||||
| Protein farnesyltransferase complexed with FPP and ethylenediamine-scaffold inhibitor 10 |
Heteromer Q04631; | 1×ZN; 1×FPP; 1×ED1; | ||||
| Assess | ||||||
| PROTEIN FARNESYLTRANSFERASE COMPLEXED WITH A FARNESYLATED K-RAS4B PEPTIDE PRODUCT |
Heteromer P01116; Q04631; | 1×ZN; 2×ACY; 1×FAR; | ||||
| Assess | ||||||
| CRYSTAL STRUCTURE OF RAT PROTEIN FARNESYLTRANSFERASE COMPLEXED WITH THE PEPTIDE SUBSTRATE TKCVFM AN… |
Heteromer Q04631; | 1×ZN; 1×FII; 2×ACY; | ||||
| Assess | ||||||
| PROTEIN FARNESYLTRANSFERASE COMPLEXED WITH FARNESYLATED K-RAS4B PEPTIDE PRODUCT AND FARNESYL DIPHOS… |
Heteromer P01116; Q04631; | 1×ZN; 1×FPP; 1×ACY; 1×FAR; | ||||
| Assess | ||||||
| Protein Farnesyltransferase Complexed with a H-Ras Peptide Substrate and a FPP Analog at 2.25A Reso… |
Heteromer Q04631; | 1×ZN; 1×FII; 1×ACY; | ||||
| Assess | ||||||
| Protein Farnesyltransferase Complexed with a TC21 Peptide Substrate and a FPP Analog at 2.3A Resolu… |
Heteromer Q04631; | 2×ACY; 1×ZN; 1×FII; | ||||
| Assess | ||||||
| Protein farnesyltransferase complexed with FPP and ethylenediamine scaffold inhibitor 2 |
Heteromer Q04631; | 1×ZN; 1×FPP; 1×ED2; | ||||
| Assess | ||||||
| Protein farnesyltransferase complexed with FPP and ethylene diamine inhibitor 4 |
Heteromer Q04631; | 1×ZN; 1×FPP; 1×ED4; | ||||
| Assess | ||||||
| Rat protein farnesyltransferase complexed with FPP and BMS-214662 |
Heteromer Q04631; | 1×ZN; 1×FPP; 1×BMV; 1×ACY; | ||||
| Assess | ||||||
| Protein farnesyltransferase complexed with FPP and caged TKCVIM substrate |
Heteromer Q04631; | 1×ZN; 1×FPP; 1×ACY; | ||||
| Assess | ||||||
| Rat protein farnesyltransferase in complex with FPP and inhibitor 2f |
Heteromer Q04631; | 4×TRS; 9×EDO; 1×FPP; 1×ZN; 1×XMY; | ||||
| Assess | ||||||
| Zinc-depleted FTase complexed with K-RAS4B peptide substrate and FPP analog. |
Heteromer P01116; Q04631; | 1×ACT; 1×FII; | ||||
| Assess | ||||||
| FTase in complex with BMS analogue 14 |
Heteromer Q04631; | 1×ZN; 1×7TO; 1×FPP; 1×DMS; | ||||
| Assess | ||||||
| FTase in complex with BMS analogue 11 |
Heteromer Q04631; | 1×ZN; 1×FPP; 1×7TM; 2×DMS; | ||||
| Assess | ||||||
| FTase in complex with BMS analogue 12 |
Heteromer Q04631; | 1×ZN; 1×FPP; 1×7TQ; | ||||
| Assess | ||||||
| Discovery of an Anion-Dependent Farnesyltransferase Inhibitor from a Phenotypic Screen |
Heteromer Q04631; | 2×ACE; 1×60I; 1×ZN; 1×MG; 1×DMA; | ||||
| Assess | ||||||
| Discovery of an Anion-Dependent Farnesyltransferase Inhibitor from a Phenotypic Screen |
Heteromer Q04631; | 2×ACE; 1×60I; 1×ZN; 1×MG; 1×PPV; | ||||
| Assess | ||||||
| Crystal structure of FTase(ALPHA-subunit; BETA-subunit DELTA C10, W102T, Y154T) in complex with Bio… |
Heteromer Q04631; | 1×ZN; 1×GBO; | ||||
| Assess | ||||||
| Crystal structure of FTase(ALPHA-subunit; BETA-subunit DELTA C10) in complex with BiotinGPP |
Heteromer Q04631; | 1×ZN; 1×GBO; | ||||
| Assess | ||||||
| Structure of FPT bound to DATFP-DH-GPP |
Heteromer Q04631; | 1×MG; 1×ZN; 1×SZH; | ||||
| Assess | ||||||
| Discovery of C-Imidazole Azaheptapyridine FPT Inhibitors |
Heteromer Q04631; | 1×MG; 1×ZN; 1×FPP; 1×Z96; | ||||
| Assess | ||||||
| Crystal structure of FTase(ALPHA-subunit; BETA-subunit DELTA C10) in complex with BMS3 and lipid su… |
Heteromer Q04631; | 1×ZN; 1×FPP; 1×3PZ; | ||||
| Assess | ||||||
| FTase in complex with BMS analogue 13 |
Heteromer Q04631; | 3×DMS; 1×ZN; 1×7TR; 1×FPP; | ||||
| Assess | ||||||
| FTase in complex with BMS analogue 16 |
Heteromer Q04631; | 4×DMS; 1×ZN; 1×FPP; 1×7TP; | ||||
| Assess | ||||||
| Crystal Structure of rat protein farnesyltransferase complexed with a benzofuran inhibitor and FPP |
Heteromer Q04631; | 5×GOL; 1×ZN; 1×FPP; 1×NH7; | ||||
| Assess | ||||||
| Structure of FPT bound to the CVIM-FPP product |
Heteromer Q04631; | 1×MG; 1×ZN; 1×2NH; | ||||
| Assess | ||||||
| Structure of Farnesyl Protein Transferase bound to PB-93 |
Heteromer Q04631; | 1×ZN; 1×FPP; 1×PB9; | ||||
| Assess | ||||||
| Aryl Tetrahydrophyridine Inhbitors of Farnesyltranferase: Glycine, Phenylalanine and Histidine Deri… |
Heteromer Q04631; | 1×ZN; 1×HFP; 1×FTH; | ||||
| Assess | ||||||
| Structure of FPT bound to GGPP |
Heteromer Q04631; | 1×ZN; 1×GRG; | ||||
| Assess | ||||||
| Structure of FPT bound to isoprenoid analog 3b |
Heteromer Q04631; | 1×ZN; 1×1NH; | ||||
| Assess | ||||||
| Structure of FPT bound to the inhibitor SCH66336 |
Heteromer Q04631; | 1×ZN; 1×FPP; 1×336; | ||||
| Assess | ||||||
| Imidazole and cyanophenyl farnesyl transferase inhibitors |
Heteromer Q04631; | 1×ZN; 1×HFP; 1×2C5; | ||||
| Assess | ||||||
| STRUCTURE OF RAT FARNESYL PROTEIN TRANSFERASE COMPLEXED WITH A CVIM PEPTIDE AND ALPHA-HYDROXYFARNES… |
Heteromer Q04631; | 1×ACT; 1×ZN; 1×HFP; | ||||
| Assess | ||||||
| Crystal Structure of rat protein farnesyltransferase complexed with a bezoruran inhibitor and FPP |
Heteromer Q04631; | 2×ACY; 1×ZN; 1×FPP; 1×NH8; 3×GOL; | ||||
| Assess | ||||||
| Structure of FPT bound to inhibitor SCH207736 |
Heteromer Q04631; | 1×ZN; 1×FPP; 1×736; | ||||
| Assess | ||||||
| Crystal Structure of Rat Farnesyl Transferase in Complex With A Potent Biphenyl Inhibitor |
Heteromer Q04631; | 1×ZN; 1×HFP; 1×FTL; | ||||
| Assess | ||||||
| Farnesyltransferase complex with tetrahydropyridine inhibitors |
Heteromer Q04631; | 1×ZN; 1×HFP; 1×FTI; | ||||
| Assess | ||||||
| CO-CRYSTAL STRUCTURE OF PROTEIN FARNESYLTRANSFERASE COMPLEXED WITH A FARNESYL DIPHOSPHATE SUBSTRATE |
Heteromer Q04631; | 1×ZN; 1×FPP; | ||||
| Assess | ||||||
| PROTEIN FARNESYLTRANSFERASE COMPLEX WITH FARNESYL DIPHOSPHATE |
Heteromer Q04631; | 1×ZN; 1×PO4; 1×FPP; | ||||
| Assess | ||||||
| Aryl Tetrahydropyridine Inhbitors of Farnesyltransferase: Glycine, Phenylalanine and Histidine Deri… |
Heteromer Q04631; | 1×HFP; 1×TIN; 1×ZN; | ||||
| Assess | ||||||
| Farnesyl transferase structure of Jansen compound |
Heteromer Q04631; | 1×ZN; 1×JAN; | ||||
| Assess | ||||||
1 SWISS-MODEL model
| Template | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 2h6h.1.B | monomer | 0.92 | 96.34 | |||
| Assess | ||||||